Clinical Trials on Renal Clear Cell Carcinoma in United States
Total 6238 results
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingMetastatic Renal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Unclassified Renal Cell Carcinoma | Stage II Renal Cell Cancer AJCC v7United States, Canada, Israel
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedRecurrent Renal Cell CancerUnited States
-
Vanderbilt-Ingram Cancer CenterAstraZeneca; Syndax PharmaceuticalsTerminatedFallopian Tube Cancer | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Recurrent Endometrial Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Primary Peritoneal... and other conditionsUnited States
-
Duke UniversityCompletedCarcinoma, Renal CellUnited States
-
University of Michigan Rogel Cancer CenterCompletedCarcinoma, Renal CellUnited States
-
Daniel George, MDNovartis; PfizerCompletedRenal Cell CarcinomaUnited States
-
National Center for Research Resources (NCRR)Duke UniversityUnknownRenal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Localized Transitional Cell Cancer of the...United States
-
Beth Israel Deaconess Medical CenterRecruitingRenal Cell CarcinomaUnited States
-
University of PennsylvaniaCompletedRenal Cell CarcinomaUnited States
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompleted
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedRenal Cell CarcinomaUnited States
-
University of PittsburghNational Institutes of Health (NIH)TerminatedRenal Cell CarcinomaUnited States
-
University of Colorado, DenverGenentech, Inc.CompletedRenal Cell CarcinomaUnited States
-
BayerTerminatedCarcinoma, Renal CellUnited States
-
Beth Israel Deaconess Medical CenterWithdrawnRenal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Completed
-
PfizerActive, not recruiting
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedRenal Cell CarcinomaUnited States
-
PfizerCompleted
-
Indiana UniversityTerminatedRenal Cell CarcinomaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; AmgenTerminatedRenal Cell CarcinomaUnited States
-
Beth Israel Deaconess Medical CenterNovartis; Pfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompletedRenal Cell CarcinomaUnited States
-
Chandru SundaramCompletedRenal Cell CarcinomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Argos TherapeuticsTerminated
-
National Cancer Institute (NCI)TerminatedRenal Cell CarcinomaUnited States
-
University of ChicagoEli Lilly and Company; Genentech, Inc.TerminatedCarcinoma, Renal CellUnited States
-
Agenus Inc.Terminated
-
Stanford UniversityCelgene CorporationCompletedKidney NeoplasmsUnited States
-
GOG FoundationNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedRenal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
University of ArizonaTerminated
-
NRG OncologyNational Cancer Institute (NCI)RecruitingMetastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Unresectable Renal Cell CarcinomaUnited States
-
Roswell Park Cancer InstituteIovance Biotherapeutics, Inc.WithdrawnMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Unresectable Renal Pelvis Urothelial Carcinoma | Unresectable Ureter Urothelial CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Metastatic MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrioid Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage... and other conditionsUnited States
-
Johns Hopkins UniversityCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Eli Lilly and CompanyCompletedMetastatic Renal Cell CarcinomaUnited States
-
Yale UniversityRecruitingRenal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Oligoprogressive | ProgressionUnited States
-
PfizerCompletedRenal Cell CarcinomaUnited States
-
University of Kansas Medical CenterUnknownRenal Cell CarcinomaUnited States
-
Jason HafronWilliam Beaumont HospitalsTerminatedRenal Cell CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterTerminatedRenal Cell CarcinomaUnited States
-
Bristol-Myers SquibbWithdrawnRenal Cell CarcinomaUnited States
-
University of California, San FranciscoNovartisCompleted
-
National Cancer Institute (NCI)TerminatedRenal Cell Carcinoma | Renal Cell Cancer | Hereditary LeiomyomatosisUnited States
-
Mayo ClinicRecruitingMalignant Solid Neoplasm | Renal Cell Carcinoma | Hepatocellular Carcinoma | Metastatic Cutaneous Melanoma | Unresectable Cutaneous Melanoma | Lung Non-Small Cell Carcinoma | Urothelial Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Recurrent Head and Neck Squamous... and other conditionsUnited States